The Neurobiology of Multiple Sclerosis

The Destructive Alliance: Interactions of leukocytes, cerebral endothelial cells and the immune cascade in pathogenesis of multiple sclerosis.Role of B cells in Pathogenesis of Multiple Sclerosis.The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis.The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?Immunopathogenesis of Multiple Sclerosis.Molecular mimicry in multiple sclerosis.Molecular 'negativity' may underlie multiple sclerosis: Role of myelin basic protein family in the pathogenesis of MS.Microchimerism and Stem Cell Tansplantation in Multiple Sclerosis.The Insulin-Like Growth Factor System in Multiple Sclerosis.Cell-derived Microparticles and Exosomes in Neuroinflammatory Disorders.Multiple sclerosis in children: Clinical, diagnostic, and therapeutic aspects.Migraine in multiple sclerosis. Multiple sclerosis as a painful disease.Multiple Sclerosis and Behavior.Cerebrospinal Fluid Analysis in Multiple Sclerosis.Multiple sclerosis in Isfahan, Iran. Gender Issues in Multiple Sclerosis.Differential Diagnosis of Multiple Sclerosis. Prognostic factors in multiple sclerosis.Neuroimaging in Multiple sclerosis.Detection of Cortical Lesions is Dependent on Choice of Slice Thickness in Patients with Multiple Sclerosis.The Role of Quantitative Neuroimaging Indices in the Differentiation of Ischemia from Demyelination - A analytical study with case presentation. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602 and -DQB1*0603 Alleles are Associated with More Severe Disease Outcome on MRI in Patients with Multiple Sclerosis.Glatiramer acetate: Mechanisms of action in multiple sclerosis. Evolving therapies for multiple sclerosis.Remyelination in multiple sclerosis.Trigeminal neuralgia: A modern-day analysis.Optic Neuritis and the Neuro-Ophthalmology of Multiple Sclerosis.Neuromyelitis Optica: New Findings on Pathogenesis.